Guggenheim Downgrades Regeneron Pharma (REGN) to Neutral
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $810.24 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja downgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Neutral with a price target of $425.00 (from $466.00).
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $422.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
- Mercury Systems (MRCY) PT Raised to $131 at Piper Sandler as 'Acceleration Continues'
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
